Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bigitha Bennychen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bio-Protocol|July 1, 2024
A Flow Cytometry-Based Method for Assessing CAR Cell Binding Kinetics Using Stable CAR Jurkat CellsAlex Shepherd, Bigitha Bennychen, Zafer Ahmed, et al.
Plos One|June 22, 2023
A simplified function-first method for the discovery and optimization of bispecific immune engaging antibodiesAlex Shepherd, Bigitha Bennychen, Anne Marcil, et al.
Nature Communications|January 23, 2023
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cellsSébastien Durand, Marion Bruelle, Fleur Bourdelais, et al.
Antibody Therapeutics|September 24, 2025
Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cellsScott McComb, Bianca Dupont, Alex Shepherd, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bio-Protocol|July 1, 2024
A Flow Cytometry-Based Method for Assessing CAR Cell Binding Kinetics Using Stable CAR Jurkat CellsAlex Shepherd, Bigitha Bennychen, Zafer Ahmed, et al.
Plos One|June 22, 2023
A simplified function-first method for the discovery and optimization of bispecific immune engaging antibodiesAlex Shepherd, Bigitha Bennychen, Anne Marcil, et al.
Nature Communications|January 23, 2023
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cellsSébastien Durand, Marion Bruelle, Fleur Bourdelais, et al.
Antibody Therapeutics|September 24, 2025
Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cellsScott McComb, Bianca Dupont, Alex Shepherd, et al.
Pageof 1